PureTech Health plc (LON:PRTC – Get Free Report)’s share price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 153.73 ($2.00) and traded as high as GBX 155.58 ($2.02). PureTech Health shares last traded at GBX 151.20 ($1.96), with a volume of 421,616 shares traded.
PureTech Health Stock Performance
The business’s fifty day simple moving average is GBX 153.73 and its 200-day simple moving average is GBX 184.98. The company has a current ratio of 3.68, a quick ratio of 2.51 and a debt-to-equity ratio of 47.27. The firm has a market cap of £362.00 million, a P/E ratio of -657.39 and a beta of 1.02.
About PureTech Health
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Further Reading
- Five stocks we like better than PureTech Health
- Do ETFs Pay Dividends? What You Need to Know
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- How is Compound Interest Calculated?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How to Plot Fibonacci Price Inflection Levels
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
